Ophthalmic Lenses · United States Digital Cognitive Assessment and Digital Therapeutics
Comparable size, CAGR, competitive structure, and regional split for Ophthalmic Lenses and United States Digital Cognitive Assessment and Digital Therapeutics, drawn from the same source-attributed evidence ledger that backs every Meridian Consensus preview.
Size & growth
USD nominal · 2025 base| Metric | Ophthalmic Lenses | United States Digital Cognitive Assessment and Digital Therapeutics |
|---|---|---|
| Market size · 2025 | $35.2B | $4537.9B |
| CAGR · 2025–2036 | 6.0% | 5.0% |
| Forecast · 2036 | $66.9B | $7802.3B |
| Industry | Healthcare | Healthcare |
Leading operators · top 3 each
Operator-level shareOphthalmic Lenses
- 01EssilorLuxottica (Essilor Division)30.7%
- 02Johnson & Johnson Vision21.4%
- 03Alcon Inc.11.0%
United States Digital Cognitive Assessment and Digital Therapeutics
- 01Biogen3.2%
- 02Akili Interactive2.2%
- 03
Regional split
Share · USD M| Region | Ophthalmic Lenses | United States Digital Cognitive Assessment and Digital Therapeutics |
|---|---|---|
| North America | 41.3%$14.6B | – |
| Europe | 23.2%$8.2B | – |
| Asia Pacific | 24.8% |
Aligned strength / weakness / opportunity / threat ledger across all markets in one frame.
2025–2036 curves overlaid on a shared axis with confidence bands and inflection markers.
Filing density, expiry cliff timing, and concentration ratios across each market’s top assignees.
Where capital is going, by sub-segment and operator type, with probability-weighted returns.
Deep competitive comparison
Full SWOT matrices, patent landscape overlay, year-by-year forecast curves, and investment thesis side-by-side for each market.
Commission the full comparison